Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 6697 - 6704 of 12099 results
U.S. Visa Processing in Turkey Suspended Amid Security Concerns; Turkey Responds in Kind
October 10, 2017| Alert| Viewpoint
OTC Drug Manufacturers: Keep Your Eyes and Ears on Congress
October 10, 2017| Blog| Viewpoint
Building a Health App? Part 4: Avoiding an FTC Enforcement Action
October 10, 2017| Blog| Viewpoint
Department of Veterans Affairs Aims to Trump State Telemedicine Rules
October 10, 2017| Blog| Viewpoint
Health Care Weekly Preview from ML Strategies – Week of October 9, 2017
October 10, 2017| Blog| Viewpoint
InsureTech Connect 2017 Panel Discussion: Maximizing Profits via Products and Alternative Business Model Innovation
October 9, 2017| Article| Viewpoint
Federal Trade Commission Announces Workshop on Competition in the Prescription Drug Market
October 9, 2017| Blog| Viewpoint
General Plastic Industrial Co. v. Canon Kabushiki Kaisha: PTAB Explains Factors for Follow-On Petitions
October 9, 2017| Blog| Viewpoint
News & Press Releases
Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE
August 15, 2025
Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.
Eleven Mintz Attorneys Named to 2025 IAM Strategy 300 List of Leading IP Strategists
August 14, 2025
Mintz announces that eleven of its attorneys have been named to the 2025 IAM Strategy 300: The World's Leading IP Strategists list, which recognizes individuals for their trailblazing work in developing and implementing strategies that maximize the value of intellectual property portfolios.
ESG-Focused Activism Persists Despite Proxy Curbs
August 12, 2025
Law360 published an article written by Mintz Members Jacob Hupart, Ellen Shapiro, and Associate Will McKitterick about the role ESG considerations continue to play in shareholder activism and proxy battles. The article also examines how recent regulatory and political developments have raised the bar for ESG-related proposals, influencing both strategy and outcomes.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|